Indications
For active immunisation of rabbits from five weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease. Onset of immunity: 3 weeks. Duration of immunity: 1 year.
Composition
- Active substance
- live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nobivac Myxo-RHD
- Active substance
- live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009
- Group
- Veterinary medicines
- Marketing authorisation holder
- Intervet International BV
- Status
- Withdrawn
- EU authorisation
- 7 Sept 2011